PURPOSE: We aimed to evaluate early response to two different corticosteroids doses after Kasai portoenterostomy for biliary atresia (BA). METHODS: A prospective, randomized trial was performed in infants from the nationwide BA registry with type 3 BA. Sixty-nine infants were randomized to receive either 4 mg/kg/day (group A, n = 35) or 2 mg/kg/day prednisolone (group B, n = 34). The corticosteroids were started on postoperative day 7, and the dose was tapered toward day 30. Results of liver function tests on days 31 and 60 were compared between the groups. RESULTS:Mean bilirubin, AST, ALT, and GGT levels did not significantly differ between the groups. However, the levels of total and direct bilirubin of infants <70 days old at surgery significantly differed between the groups. Four patients from group A and five from group B, dropped out of the study. Complications during the first month after PE were comparable between the groups. CONCLUSIONS: An initial 4 mg/kg/day dose did not significantly improve liver function, except that bilirubin levels were lower in the subgroup of infants <70 days old at surgery. There were no significant complications with either dose of corticosteroids.
RCT Entities:
PURPOSE: We aimed to evaluate early response to two different corticosteroids doses after Kasai portoenterostomy for biliary atresia (BA). METHODS: A prospective, randomized trial was performed in infants from the nationwide BA registry with type 3 BA. Sixty-nine infants were randomized to receive either 4 mg/kg/day (group A, n = 35) or 2 mg/kg/day prednisolone (group B, n = 34). The corticosteroids were started on postoperative day 7, and the dose was tapered toward day 30. Results of liver function tests on days 31 and 60 were compared between the groups. RESULTS: Mean bilirubin, AST, ALT, and GGT levels did not significantly differ between the groups. However, the levels of total and direct bilirubin of infants <70 days old at surgery significantly differed between the groups. Four patients from group A and five from group B, dropped out of the study. Complications during the first month after PE were comparable between the groups. CONCLUSIONS: An initial 4 mg/kg/day dose did not significantly improve liver function, except that bilirubin levels were lower in the subgroup of infants <70 days old at surgery. There were no significant complications with either dose of corticosteroids.
Authors: Mark Davenport; Mark D Stringer; Sarah A Tizzard; Patricia McClean; Giorgina Mieli-Vergani; Nedim Hadzic Journal: Hepatology Date: 2007-12 Impact factor: 17.425
Authors: Mauricio A Escobar; Colleen L Jay; Ronald M Brooks; Karen W West; Frederick J Rescorla; Jean P Molleston; Jay L Grosfeld Journal: J Pediatr Surg Date: 2006-01 Impact factor: 2.545
Authors: Rebecka L Meyers; Linda S Book; Molly A O'Gorman; W Daniel Jackson; Richard E Black; Dale G Johnson; Michael E Matlak Journal: J Pediatr Surg Date: 2003-03 Impact factor: 2.545
Authors: Laurens D Eeftinck Schattenkerk; Gijsbert D Musters; David J Nijssen; Wouter J de Jonge; Ralph de Vries; L W Ernest van Heurn; Joep P M Derikx Journal: Innov Surg Sci Date: 2021-08-17
Authors: Mary Elizabeth M Tessier; Sanjiv Harpavat; Ross W Shepherd; Girish S Hiremath; Mary L Brandt; Amy Fisher; John A Goss Journal: World J Gastroenterol Date: 2014-08-28 Impact factor: 5.742